Tag: Moderna mFLUSIVA
FDA Approves Moderna’s mFLUSIVA, the First mRNA-Based Seasonal Influenza Vaccine
Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved mFLUSIVA (mRNA-1010), making it the first mRNA-based vaccine approved for seasonal influenza.
The vaccine...